{
  "report_rows": [
    {
      "kpi": "Revenue",
      "prediction": "IN-LINE",
      "answer": "pred ~$2.30B vs. cons $2.28B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Total Segment EBITDA",
      "prediction": "BEAT",
      "answer": "pred ~$375M vs. cons $370M",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adjusted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$0.24 vs. cons $0.23",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Total Segment EBITDA",
      "prediction": "LOWER",
      "answer": "guide ~$1.70B vs. cons $1.73B (FY2027)",
      "confidence": "LOW"
    },
    {
      "kpi": "Free cash flow",
      "prediction": "BETTER",
      "answer": "guide ~$760M vs. cons $740M (FY2027)",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": 1.6,
  "day1_confidence": "LOW",
  "day5_residual_pct": 0.6,
  "day5_path": "FADE",
  "day5_rationale": "Day-1 residual of ~+1.6% fades to ~+0.6% by day 5: modest Q4 EBITDA/EPS upside is partly pre-priced, while an implied FY2027 EBITDA outlook of ~$1.70B versus consensus of $1.73B limits estimate revisions despite stronger cash flow.",
  "day5_confidence": "LOW"
}